FIELD: chemistry.
SUBSTANCE: invention relates to a mixture of diastereomeric compounds 
where C* denotes a mixture of R- and S-isomers; and the R-isomer constitutes over 50% of the mixture with respect to the S-isomer in the C* position.
EFFECT: obtained mixture is effective for inhibiting serine protease.
16 cl, 8 tbl, 6 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DEUTERATED HEPATITIS C PROTEASE INHIBITORS | 2007 |
|
RU2465264C2 |
| METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
| METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
| THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
| THIAZOLIDINEDIONE ANALOGUES FOR TREATING DIABETES AND DYSLIPIDEMIA | 2008 |
|
RU2486179C2 |
| NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
| SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
| THIAZOLIDINEDIONE ANALOGUES | 2007 |
|
RU2445957C2 |
| MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
| 2-AMIDO-4-ARYLOXY-1-CARBONYLPYRROLIDINE DERIVATIVES AS SERINE PROTEASE INHIBITORS, PARTICULARLY NS3-NS4A HCV PROTEASE | 2004 |
|
RU2440368C2 |
